2022. 31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age. SKIN The Journal of Cutaneous Medicine. 6, 2 (Mar. 2022), s24. DOI:https://doi.org/10.25251/skin.6.supp.24.